Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Research Council grant · Running

CLOVIS The cerebellum: a transdiagnostic personalised target for neuromodulation in psychiatry

Coordinator
Universite Paris Xii Val De Marne, France
Runs
1 September 2026 to 31 August 2031
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101219798

What the project is doing

In the project's own words, from its summary on CORDIS.

Have you ever had that moment where you reach for something, convinced it is heavy, but it is actually light? Your arm jolts upward, correcting itself before you realise the difference. This split second adjustment is thanks to your cerebellum, the part of your brain responsible for fine-tuning movements by integrating sensory feedback. While the cerebellum is traditionally associated with motor control, it plays a similar role in cognitive functions.

Despite occupying 10% of the brain’s volume, the cerebellum houses more than 50% of its neurons, many of which are integral to higher cognitive processes. Its extensive connections with brain regions responsible for complex thought and emotion make it a promising target for non-invasive brain stimulation (NIBS) especially in addressing the resistant cognitive and negative symptoms observed in psychiatric disorders such as schizophrenia, bipolar disorder, and autism.

However, a significant challenge persists: clinical research on NIBS often relies on a trial-and-error approach, while fundamental research has yet to fully translate electrophysiological findings into circuit-level applications that can guide clinical interventions. To bridge this gap, I will develop normative models from large-scale MRI cohorts to identify patients who are most likely to benefit from cerebellar stimulation and then derive a personalised cerebellar target.

Concurrently, animal studies using ultra-high field MRI will be conducted to determine optimal cerebellar stimulation parameters. With intracranial recordings, I will explore the neuroplastic changes induced by NIBS in humans. The project will culminate in a proof-of-concept clinical trial aiming at improving cognitive and negative symptoms across schizophrenia, bipolar disorder and autism with cerebellar NIBS. This multidisciplinary project has the potential to revolutionize the treatment of resistant psychiatric symptoms and catalyse advancements in the understanding of NIBS.

Topics

Who is involved

OrganisationCityCountryRole
Universite Paris Xii Val De MarneCreteilFranceCoordinator
Commissariat a L Energie Atomique Et Aux Energies AlternativesParisFranceParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI